Biotech Week articles from April 2003

Biotech Week archives from April 2003

Six-week, six-shot regimen works for more than one season.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Johns Hopkins researchers last year reported that an experimental treatment for severe ragweed allergy consisting of just six shots in 6 weeks dramatically reduced allergic symptoms such as runny nose,...

Vaporized hydrogen peroxide may be best method of decontamination.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Steris Corp.'s subsidiary, Strategic Technology Enterprises, Inc., presented an overview of its proprietary Vaporized Hydrogen Peroxide (VHP) technology as a safer and more environmentally friendly...

Coretherm system launched for office-based treatment of BPH.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- ACMI Corporation and ProstaLund Operations AB announced the launch of the CoreTherm System for office-based treatment of Bening Prostate Hyperplasia (BPH). ProstaLund recently received PMA clearance...

New database of nucleotide and amino acid sequences launched.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- FIZ Karlsruhe, a provider of information services in Europe, and European partner of science and technology online service STN International, has announced the launch of the PCTGEN database, a new...

Stabilization of dry powder vaccine formulations enhanced by rapid freezing.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Stabilization of alum-adjuvanted vaccine dry powder formulations was enhanced by a rapid freezing technique followed by lyophilization. "Studies were performed to elucidate the mechanism of alum gel...

Scientific panel finds long-lasting vaccine for Africa promising.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The Meningitis Vaccine Project (MVP), a partnership between the World Health Organization (WHO) and the Seattle-based Program for Appropriate Technology in Health (PATH), has announced a major milestone...

Direct continuous method developed for monitoring infection in a mouse model.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Researchers in the U.S. have reported development of "a rapid, continuous method for real-time monitoring of biofilms, both in vitro and in a mouse infection model, through noninvasive imaging of...

Exclusive license agreement signed for dopamine stabilizer technology.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- A. Carlsson Research AB, the Gothenburg-based pharmaceutical R&D company, announced that it has entered into a research collaboration granting Merck & Co., Inc., the license to develop and market...

Susceptibility of Lactobacillus spp. to antimicrobial agents studied.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Researchers in Denmark recently reported their findings on the susceptibility of various species of Lactobacillus to antimicrobial agents. They said this work "is a prerequisite for differentiating...

Dale named as new board member.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Michael D. Dale, president and CEO of ATS Medical, Inc., (ATSI) announced that Eric W. Sivertson has been appointed to the ATS Medical board of directors. Sivertson joins the ATS Board with over 25...

Medical products company announces exclusive distribution agreement.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced that it has signed a distribution agreement with T. Chatani and Co., Ltd., for the...

Annual charitable giving campaign results in $6.6M contribution.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories, its employees, and retirees pledged more than $6.6 million to support health and human service organizations during the company's 2002 annual charitable giving campaign. The...

HPLC validation requirements of the FDA, USP, and ICH.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The differences and similarities between the validation requirements of the U.S. Food and Drug Administration, the U.S. Pharmacopoeia, and the International Conference on Harmonization are explained in...

Neogen acquires Scottish company.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Neogen Corp. (NEOG) announced that it has acquired Adgen, Ltd., a private company based in Ayr, Scotland. Since its founding in 1994, Adgen has been a major distributor of Neogen products in...

Supervisory board names new member.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The Supervisory Board of Aegon N.V. (AEG) intends to appoint Leo M. van Wijk as a member of the Supervisory Board of Aegon N.V., as per the Annual General Meeting of Shareholders. Since 1997, Van...

National medical director named for women's health.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Aetna announced that Cheryl Pegus, MD, MPH, has been appointed National Medical director for Women's Health, reporting to Michael Reardon, MD, Head of Member Advantage Programs. "A cardiologist by...

Advanced GeneChip brand mouse, rat expression arrays launched.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) announced that it will begin taking orders for state-of-the-art versions of its mouse and rat expression arrays, the GeneChip Mouse Expression Set 430 and the GeneChip Rat...

Hand-assisted laparoscopic liver surgery is successful.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Hand-assisted laparoscopic liver surgery is successful. According to recent research from Japan, "We report a case of laparoscopic left lobectomy combined with right hemicolectomy for cystic liver...

Pittsburgh allergic disease specialists identify molecular clue to asthma.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Children who suffer from asthma or allergic rhinitis have a diminished ability to stimulate dendritic cell interleukin-10 production (IL-10), which may contribute to the cause of their disease,...

CD40 ligand trimer augments cytotoxic T-cell response.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a novel method for improving the immune response to tuberculosis infection. Buka Samten and colleagues at...

Shareholders approve stock split for device company.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The shareholders of Angiotech Pharmaceuticals, Inc., (ANPI; ANP), at the company's annual general meeting of shareholders, approved a 2-for-1 stock split. In light of receiving shareholder approval,...

Financial analysts, money managers hear after-market presentation.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR), in an after-market presentation before the Financial Analysts and Money Managers Society of New York, reported that revenues for 2002 reached approximately $4.0 million, up...

Pharma company names West as vice president of corporate communications.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Anthem, Inc., (ATH) announced that Edward A. West has been named to the newly created position of vice president of corporate communications. He will be responsible for developing and implementing a...

Optimization of therapeutics can be accomplished by directed evolution.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Optimization of therapeutics can be accomplished by directed evolution. According to a study from the United States, "Directed evolution is a broadly applicable technology platform that is ideally...

2002 revenue increases to $26.4M for prostate cancer drug maker.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced consolidated financial results for the fourth quarter and the year ended December 31, 2002. For the year 2002, total revenues increased to $26.4 million,...

Four-month prostate cancer product launched.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced the launch of 4-month Eligard 30mg (leuprolide acetate for injectable suspension) product for the palliative treatment of advanced prostate cancer. ...

Quarterly net loss of $0.01 per share reported by nutritional supplement maker.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- AutoImmune, Inc., (AIMM) reported a net loss of $0.25 million, or $0.01 per share basic and diluted, for the 3 months ended December 31, 2002, compared with net loss of $0.10 million, or $0.01 per share...

Zyomyx adds to its growing roster of customers.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Zyomyx, Inc., announced that Aventis has agreed to purchase Zyomyx's complete Protein Profiling Biochip System, featuring Zyomyx's first protein profiling biochip, the Human Cytokine Biochip. The...

Tibial nerve injury is a viable method of studying neural regeneration in mice.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Tibial nerve injury is a viable method of studying neural regeneration in mice. According to recent research from the United States, "Longitudinal studies have established that functional recovery...

Mayo Clinic to advance animal-to-human transplant research.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The Mayo Clinic and Baxter Healthcare Corp. announced a special grant from Baxter to Mayo, under which Mayo will assume full control and ownership of Baxter's xenotransplantation program and will...

Research: At-home dialysis therapy may be an effective option.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Research findings from the European APD (automated peritoneal dialysis) Outcomes Study (EAPOS), suggest that APD, a home-based dialysis treatment for people with end-stage renal disease (ESRD), is a...

Recent observations of aggregation in collected blood to be studied.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- While extensive tests conducted by the U.S. Food and Drug Administration (FDA) as well as Baxter Healthcare Corporation have found no association between containers used in the collection of blood and...

The Versant HCV RNA qualitative assay is called reliable in multicenter study.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The Versant HCV RNA qualitative assay is called reliable in a multicenter study. "We report the results of a multicenter evaluation of a new assay for the detection of hepatitis C virus (HCV) RNA in...

FDA approves Avelox (moxifloxacin HCl).
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application for Avelox (moxifloxacin HCl) Tablets/I.V. as a treatment for community-acquired pneumonia (CAP) due to...

Biotech firm plans to test vaccine on humans by year's end.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- A San Diego biotechnology firm says it hopes to begin human testing of its experimental anthrax vaccine by year's end. Several companies and government researchers are racing to create a better...

Stock buy back program announced.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- BioReliance Corporation (BREL) announced that its board of directors has authorized the repurchase of up to 500,000 shares of the company's common stock from time to time on the open market or in...

Bone graft company announces approval of method for cell differentiation.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Biocoral, Inc., (BCRA) announced that recently, the United States Patent and Trademark Office (USPTO) approved and granted a patent to Bio Holdings International, Ltd., Biocoral, Inc.'s wholly-owned...

Neuroscience research collaboration signed with Howard Florey Institute.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Bionomics announced that it has entered into a research collaboration with the Howard Florey Institute of Experimental Physiology and Medicine to advance Bionomics' research and development programs in...

Clinical pathways for total joint arthroplasty may reduce costs, hospital stays.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Clinical pathways for total joint arthroplasty may reduce costs, hospital stays. According to recent research from the United States, "Although many hospitals have implemented clinical pathways to...

Stentless porcine/pericardial conduit treats an aortic fungal false aneurysm.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Stentless porcine/pericardial conduit treats an aortic fungal false aneurysm. According to a study from England, "Fungal prosthetic valve endocarditis is an uncommon but serious condition with high...

Agreement reached resolving antitrust proceedings.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb (BMY) announced that it has reached an agreement with the U.S. Federal Trade Commission on the terms of a proposed consent decree that would resolve antitrust proceedings relating...

ATP is a biomarker of viable microorganisms in clean-room facilities.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Measurement of intracellular ATP is an indicator of viable microbial contamination in clean-rooms, CALTECH biotechnologists report. "A new firefly luciferase bioluminescence assay method that...

FDA accepts Ranexa new drug application for filing.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- CV Therapeutics, Inc., (CVTX) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's new drug application (NDA) for Ranexa (ranolazine) for filing. The FDA received...

Mossman named president of pharma business unit.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Cambrex Corporation (CBM) announced that Gary L. Mossman has joined the company as president of the Cambrex Pharma Business Unit with overall responsibility for accelerating the growth of products and...

Extension given by NASDAQ to meet requirements for continued listing.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- CardioGenesis Corporation (CGCP), the market leader in angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous Myocardial Revascularization (PMR), announced that a NASDAQ Listing...

Merger of surgical specialty companies approved by shareholders.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) and Gish Biomedical, Inc., (GISH) announced that at special meetings held yesterday their respective shareholders approved proposals necessary to effect the merger...

First spine procedure performed in U.S. using new Dynesys system.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Centerpulse Spine-Tech announced that Reginald Davis, neurosurgeon at Greater Baltimore Medical Center in Baltimore, Maryland, performed the first procedure in the United States to treat lower back and...

Insurance company reports fourth quarter net income of $4.2M, 2003 outlook.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Ceres Group, Inc., (CERG) reported net income of $4.2 million ($0.12 per diluted share on 34.2 million weighted average shares outstanding) for the fourth quarter ended December 31, 2002, excluding an...

Roth joins board of directors.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Chiral Quest, Inc., (CQST) announced that Stephen Roth, PhD, cofounder, and current chairman of the board of Neose Technologies joined the board of directors of Chiral Quest. Stephen Roth...

A new tri-leaflet mechanical valve has excellent blood compatibility.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- A new tri-leaflet mechanical valve has excellent blood compatibility. According to recent research from the United States, "An ideal heart valve prosthesis, which has both the flow dynamic...

Regan named vice president for manufacturing.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Corgentech, Inc., announced that Jack Regan has been appointed vice president for manufacturing. Regan joins Corgentech from Genentech, where he served as senior director of manufacturing...

Seattle biotech raises $40M in Series B financing, appoints board members.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Corus Pharma has successfully raised $40 million in a Series B preferred stock offering. Novo A/S, RBC Capital Partners, and JPMorgan Partners led the financing. MDS Capital and Integra Ventures,...

Dietary supplement industry to review FDA's proposed GMPs.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- The Council for Responsible Nutrition (CRN) and its member companies intend to carefully review and comment on the good manufacturing practices (GMPs) proposed rule issued by the U.S. Food and Drug...

Alliance targets development of next-generation genetic profile tests.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- DNAPrint (DNAP) announced that it has entered into a collaborative agreement with GeneLink (GNLK) to develop new genetic assessments for personalization of cosmetics and personal care product marketing....

Injection of DTI-015, a mix of BCNU in ethanol, stabilized active gliomas.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Injection of DTI-015, a mix of BCNU in ethanol, stabilized active gliomas. "DTI-015 (BCNU in 100% ethanol) utilizes solvent facilitated perfusion for the intratumoral treatment of gliomas. The...

Ipsilateral free fibula transfer avoids using vessels at the recipient site.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Ipsilateral free fibula transfer avoids using vessels at the recipient site. According to a study from the United States, "We describe an ipsilateral free fibula transfer for segmental femur...

Data from first human trial of inhaled ISS for asthma released at AAAAI.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Dynavax Technologies reported phase I clinical data demonstrating the safety and biological activity of its inhaled ISS (immuno-stimulatory DNA sequence) for the treatment of asthma. The results...

Alpha-tocopherol decreases alpha-tocotrienol but not gamma-tocotrienol.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Dietary alpha-tocopherol decreases alpha-tocotrienol but not gamma-tocotrienol concentration in rats. According to recent research from Japan, "We previously showed that alpha- and...

Major expansion initiated to increase pharmaceutical sales.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Eisai, Inc., a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., announced that it is strengthening its national sales force by adding an additional 150 sales representatives. The...

Negotiations to partner oral insulin no longer pursued; clinical data released.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) announced a delay related to a previously disclosed near-term milestone to secure a partnership for its oral insulin candidate. The oral insulin partnership had...

Biopharmaceutical receives third patent for oral small molecule program.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR), a biopharmaceutical company focused on discovering and developing high-density lipoprotein (HDL)-targeted therapies for the treatment of cardiovascular diseases,...

NASDAQ panel hearing date set for appeal of therapeutics company delisting.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Essential Therapeutics, Inc., (ETRX) announced that a NASDAQ Listing Qualification Panel hearing date was set for March 20, 2003, and the company described its plans to divest of a portion of its...

Chief operating officer, chief commercial officer resign.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- First Horizon Pharmaceutical Corporation (FHRX) announced the resignations of Bala Venkataraman, chief operating officer, and Christopher Offen, chief commercial officer, effective immediately. The...

NIAID to fund development of clinical production for MSP-1 malaria vaccine.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- GTC Biotherapeutics, Inc., (GTCB) announced that the National Institute of Allergy and Infectious Diseases (NIAID) has approved a proposal to fund development of clinical-grade production for a...

Acquisition of women's healthcare products considered.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Galen Holdings PLC, the international pharmaceutical company, announced that it and its wholly-owned subsidiary, Galen Limited, have entered into two conditional agreements with Pfizer, Inc., to acquire...

Pfizer to sell three products to British company.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc., said that it has agreed to sell its oral contraceptives, Estrostep and Loestrin, and its hormone replacement therapy, femhrt, to Galen Holdings, PLC, of Britain for $359 million in cash....

Strategic partnership with tissue bank announced.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- GenSci Regeneration Sciences, Inc., The OrthoBiologics Technology Company, announced that it has entered into an agreement with AlloSource, one of the nation's largest non-profit tissue bank...

Method for identifying new tumor antigens developed.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX; GX1) announced that it has added to its technology portfolio by expanding the license with the University of British Columbia in Vancouver, Canada. The added technology,...

New York bank named as strategic financial partner.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Genesis Bioventures, Inc., (GBI) (GBI), announced the execution of agreements to appoint a New York based investment bank as its financial advisor. The company has recently announced the proposed...

SR Pharma ready to move to phase II with AVAC.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- SR Pharma, plc, and Genesis Research and Development Corp. (GEN) announced the successful completion of a phase I safety study of AVAC, a derivative of M. vaccae, for the treatment of atopic dermatitis...

Insulin-like growth factor gene transfer rejuvenates the injured heart.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Insulin-like growth factor gene transfer is a viable means of treating hearts injured by ischemia, researchers say. "We have characterized the effect of...

Lynx announces transcriptome study.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Lynx Therapeutics, Inc., (LYNX) announced an agreement for a comparative transcriptome study with the Genome Institute of Singapore at the National University of Singapore (GIS). As part of the...

Biosurgery company reports 11% growth in its second year.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Genzyme Biosurgery (GZBX), a division of Genzyme Corp., reported financial results for the fourth quarter and full year of 2002. In its second full year of operations, Genzyme Biosurgery reported...

Genetics company reports 12% fourth quarter revenue increase.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Genzyme General (GENZ), a division of Genzyme Corp., reported financial results for the fourth quarter of 2002 and for the year. In the fourth quarter, revenues increased 12% to $298.0 million,...

Oncology company reports total annual revenue increase of 40%.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. reported that total revenues for Genzyme Molecular Oncology (GZMO) in 2002 increased more than 40% over 2001 based on the strength of its research collaborations and licensing agreements...

Rat study assesses liposomes' mucoadhesive properties in delivery of calcitonin.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Pharmacologists in Japan conducted a study in rats to assess the mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in oral delivery of calcitonin. To ready...

$10M donated to support academic research.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) and the University of Pennsylvania (Penn) School of Medicine announced that GSK has provided Penn with an unrestricted grant of $10 million to support academic research. "We...

Pharmaceutical companies continue increasing biotechnology investments.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Pharmaceutical powerhouses, such as GlaxoSmithKline, have expanded their pipelines to replace billion-dollar products by investing in promising drugs from outside their companies' development groups....

Past, present, and future of vaccine technology reviewed.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- A review covering the past achievements, present roadblocks, and future promises of vaccine technology has been published. According to recent research from Belgium, "Of all the branches of modern...

Solentix to purchase anti-inflammatory platform.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Solentix BioSciences, Inc., announced the proposed purchase of an anti-inflammatory research platform from Gliatech, Inc., (GLIAQ). Gliatech entered a motion yesterday in the U.S. Bankruptcy Court...

Rodell named chairman, CEO.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- GlobeImmune, Inc., announced the appointment of Timothy C. Rodell, MD, as CEO and chairman of the board of directors. Rodell has previously been serving as a consultant to, and interim CEO of, the...

First use of Cancion cardiac recovery system in a human has short-term success.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- First use of Cancion cardiac recovery system in a human has short-term success. According to a study from Austria, "Animal studies have shown clearly that a peripheral circulatory support system can...

Silicone oil keratopathy occurred in a photorefractive keratectomy-treated eye.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- Silicone oil keratopathy occurred in a photorefractive keratectomy-treated eye. "Three years after uneventful excimer laser photorefractive keratectomy in both eyes, a 34-year-old man sustained a...

New techniques in reconstruction offer alternatives to leg amputation.
April 2, 2003... 2003 APR 2 - (NewsRx.com & NewsRx.net) -- New techniques in reconstruction offer alternatives to leg amputation. According to a study from England, "Major congenital limb deficiencies are rare and the experience of most orthopedic surgeons...